[1] |
Irvine SR. A newly defined vitreous syndrome following cataract surgery[J]. Am J Ophthalmol,1953,36(5):599-619.
|
[2] |
Ursell PG, Spalton DJ, Whitcup SM, et al. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity[J]. J Cataract Refract Surg,1999,25(11):1492-1497.
|
[3] |
Gharbiya M, Cruciani F, Cuozzo G, et al. Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification[J]. Eye (Lond),2013,27(5):605-611.
|
[4] |
Mentes J, Erakgun T, Afrashi F, et al. Incidence of cystoid macular edema after uncomplicated phacoemulsification[J]. Ophthalmologica,2003,217(6):408-412.
|
[5] |
Cagini C, Fiore T, Iaccheri B, et al. Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery[J]. Curr Eye Res,2009,34(12):1036-1041.
|
[6] |
Henderson BA, Kim JY, Ament CS, et al. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment[J]. J Cataract Refract Surg,2007,33(9):1550-1558.
|
[7] |
O′Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care[J]. Curr Med Res Opin, 2005,21(9):1131-1137.
|
[8] |
Nichols J, Snyder RW. Topical nonsteroidal anti-inflammatory agents in ophthalmology[J]. Curr Opin Ophthalmol,1998,9(4):40-44.
|
[9] |
Miyake K, Masuda K, Shirato S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial[J]. Jpn J Ophthalmol,2000,44(1):58-67.
|
[10] |
Mathys KC, Cohen KL. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema[J]. Eye (Lond),2010,24(1):90-96.
|
[11] |
Sivaprasad S, Bunce C, Wormald R. Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review[J]. Br J Ophthalmol,2005, 89(11):1420-1422.
|
[12] |
Elsawy MF, Badawi N, Khairy HA. Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery[J]. Clin Ophthalmol,2013,7:1245-1249.
|
[13] |
Wakitani Y, Sasoh M, Sugimoto M, et al. Macular thickness measurements in healthy subjects with different axial lengths using optical coherence tomography[J]. Retina,2003,23(2):177-182.
|
[14] |
Kusbeci T, Eryigit L, Yavas G, et al. Evaluation of cystoid macular edema using optical coherence tomography and fundus fluorescein angiography after uncomplicated phacoemulsification surgery[J]. Curr Eye Res,2012,37(4):327-333.
|
[15] |
赵家良,黎晓新,董冬生,等. 普南扑灵滴眼剂治疗白内障术后眼炎症和非感染性眼前段炎症的临床评价[J]. 眼科研究,2000, 18(6):560-564.
|
[16] |
Pecora JL. Ibuprofen in the treatment of macular edema and central serous chorioretinopathy[J]. Ann Ophthalmol,1979,11(3):494-495.
|
[17] |
Caccavale A, Romanazzi F, Imparato M, et al. Low-dose aspirin as treatment for central serous chorioretinopathy[J]. Clin Ophthalmol,2010,4:899-903.
|
[18] |
Nicholas S, Riley A, Patel H, et al. Correlations between optical coherence tomography measurement of macular thickness and visual acuity after cataract extraction[J]. Clin Experiment Ophthalmol,2006,34(2):124-129,194.
|
[19] |
Perente I, Utine CA, Ozturker C, et al. Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography[J]. Curr Eye Res,2007,32(3):241-247.
|